Address
Guanzhou Life Science Innovation Center, Room 2502, Towe A,Haizhu District, Guangzhou, GUANGDONG, China
Press Release about Fulmz
GUANGZHOU, China, Feb. 5, 2024 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain management, is pleased to announce the approval of the Investigational New Drug (IND)…
GUANGZHOU, China, Jan. 10, 2024 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that China National Medical Products Administration (NMPA) approved the Investigational…
Monday, November 13, 2023 Background/Purpose: Tyrosine Kinase 2 (TYK2) is a signaling protein within the Janus kinase (JAK) family. It plays a crucial role in transmitting signals from pro-inflammatory cytokines like IL-23, IL-12, and Type I IFN, which contribute to Immune…
GUANGZHOU, China, May 22, 2023 /PRNewswire/ — Guangzhou Fermion Technology Co., Ltd. (Fermion), a clinical-stage AI-based drug discovery company that specializes in developing drugs for autoimmune diseases and pain, has announced today that it will release updated data of FZ007, FZ002, and…
